COL1A1 rs1800013: What Your Genotype Means
The rs1800013 variant is a genetic polymorphism located within the COL1A1 gene, which provides instructions for creating type I collagen. This variant is frequently studied for its potential influence on collagen synthesis, bone mineral density, and the structural integrity of connective tissues like tendons.
What each genotype means
Typical collagen synthesis profile
This genotype represents the most common configuration at this site in the COL1A1 gene. Research into this specific Sp1 transcription factor binding-site variant has yielded mixed results regarding its influence on bone mineral density and tendon elasticity, with some studies suggesting it may be associated with different mechanical properties of connective tissue than the T allele. Because the evidence is limited and often conflicting across different populations, this genotype should not be used to predict specific physical performance or fracture risk.
This is the most common genotype, found in the majority of individuals across most global populations.
Intermediate collagen synthesis profile
Carrying one copy of the T allele at this site may influence the regulation of type I collagen synthesis, though the clinical significance remains a subject of ongoing scientific debate. Some studies have investigated whether this variant contributes to variations in bone mineral density or susceptibility to soft tissue injuries, but findings are inconsistent and often lack statistical strength. You should view this as a common genetic variation rather than a definitive indicator of health or physical capability.
This genotype is carried by a significant portion of the population, particularly in individuals of European ancestry where the T allele frequency is approximately 15-20%.
Variant collagen synthesis profile
This genotype results in two copies of the T allele at the Sp1 binding site, which has been studied for its potential role in modulating collagen production. While some research has explored associations between this genotype and differences in bone density or ligament injury risk, the evidence is limited and results vary widely between different studies and ethnic groups. It is important to recognize that this variant is not a diagnostic marker, and any concerns regarding bone health or connective tissue should be discussed with a healthcare professional.
This is the least common genotype, occurring in a smaller percentage of the population, especially in European groups, and is rare in East Asian and African populations.
Understanding the Variant
The rs1800013 variant, often referred to in scientific literature as the Sp1 binding-site polymorphism or the +1245 G/T polymorphism, is located within an intronic regulatory region of the COL1A1 gene. This gene is situated on chromosome 17 and encodes the pro-alpha1 chain of type I collagen. Unlike variants that change the actual protein sequence, this SNP is located in a region that regulates how much collagen is produced. By altering a binding site for the Sp1 transcription factor, the variant may influence the efficiency of gene expression. Because type I collagen is the most abundant protein in the human body, providing structural support to bones, skin, and tendons, even subtle changes in its production levels have been the subject of extensive research regarding their impact on physical traits and health outcomes.
The Role of COL1A1
The COL1A1 gene is essential for the formation of type I collagen, a triple-helical protein that acts as a primary structural component of the extracellular matrix. This protein is vital for the mechanical strength and elasticity of connective tissues. In bone, it provides a scaffold for mineralization, while in tendons and ligaments, it ensures the tissue can withstand mechanical loading. When the production of these collagen chains is disrupted or altered, it can affect the overall quality and density of these tissues. While severe mutations in COL1A1 are known to cause conditions like osteogenesis imperfecta, the rs1800013 variant is considered a common polymorphism rather than a disease-causing mutation. It is investigated primarily for its role in modulating the risk of complex, multifactorial conditions related to bone and connective tissue health.
Research and Associations
Research into rs1800013 has primarily focused on its association with bone mineral density (BMD) and the risk of osteoporotic fractures. Meta-analyses have suggested that the T allele may be associated with a modest reduction in bone density and a potentially higher risk of fractures in certain populations. Additionally, some studies have explored links between this variant and tendon elasticity or the risk of ligament injuries, such as tennis elbow or cruciate ligament tears. However, the evidence strength for these associations is generally considered limited. The effects observed in studies are often small, and results have been inconsistent across different cohorts and ethnic groups. It is important to note that bone health is influenced by a wide array of genetic and environmental factors, including nutrition, physical activity, and hormonal status, making it difficult to isolate the impact of a single SNP.
Population Frequency
The frequency of the rs1800013 variant varies significantly across different ancestral populations. In European populations, the T allele frequency is typically observed between 0.15 and 0.20. In contrast, the variant is much less common in East Asian and African populations, where the T allele frequency is generally reported to be below 0.05. These differences highlight the importance of considering ancestry when interpreting genetic data, as the prevalence of specific genotypes can differ widely depending on one's genetic background. Because the variant is more common in some groups than others, the potential impact of the genotype on health traits may also vary by population.
Interpreting Your Results
If you have information about your rs1800013 genotype, it is important to view it within the context of your overall health. This variant is not a diagnostic tool and cannot predict whether you will develop osteoporosis or experience a ligament injury. Genetic associations are statistical observations made across large groups of people and do not necessarily apply to an individual's specific health trajectory. Factors such as lifestyle, diet, and regular medical screenings are far more significant predictors of bone and connective tissue health. If you are concerned about bone density or injury risk, you should consult with a healthcare professional. They can provide personalized guidance based on your clinical history, physical examination, and appropriate diagnostic testing, rather than relying on a single genetic marker.
How common is this variant?
The T allele frequency is approximately 0.15 to 0.20 in European populations, while it is less than 0.05 in East Asian and African populations.
Frequently asked questions
Does the rs1800013 variant cause osteoporosis?
No, this variant does not cause osteoporosis. It is a common genetic polymorphism that has been statistically associated with modest differences in bone mineral density, but it is only one of many factors that influence bone health.
Can I use this SNP to predict my risk of a sports injury?
While some research has explored links between this variant and tendon or ligament health, the evidence is limited and inconsistent. It cannot be used to reliably predict your personal risk of sustaining a sports injury.
Should I take supplements if I have the T allele?
You should not make changes to your health regimen based on this genetic variant. Please discuss your bone health and any potential need for supplements with your physician or a registered dietitian.
Is this variant the same as the mutations that cause Ehlers-Danlos syndrome?
No, this variant is a common polymorphism and is distinct from the rare, pathogenic mutations in the COL1A1 gene that are known to cause severe connective tissue disorders like Ehlers-Danlos syndrome or osteogenesis imperfecta.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800013?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in COL1A1
This SNP is linked to an age-protective methylation marker in collagen genes, influencing perceived facial aging.
The Sp1 binding site polymorphism in COL1A1 has been extensively studied for associations with bone mineral density (BMD) and fracture risk, though results remain inconsistent across different populations.
Regulates Sp1 binding affinity within the COL1A1 regulatory promoter, modulating baseline bone mineral density and connective tissue flexibility traits.
A promoter polymorphism (-1997G/T) in type I collagen alpha 1 that regulates transcriptional activity and alters susceptibility to anterior cruciate ligament ruptures and tendon pathology.
Intronic collagen type I alpha 1 variant associated with cruciate ligament rupture risk and tendon tensile stiffness in sports performance.
Variant in COL1A1 linked to dermal matrix elasticity, skin thickness, and vulnerability to dermal wrinkle formation.